AI screening for early colorectal cancer detection
Part of Cancer, Digestive system clinical trials.
This study uses an artificial intelligence model to analyze test results from the fecal immunochemical test (FIT) to help find colon cancer early. You may benefit if you are 50-69 and had a positive FIT result as part of a screening program.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 69 years old
- You took part in a fecal blood screening program and your test was positive
- You are able to understand Italian
- You have not had your colon removed or any bowel surgery before
- You have not had a colonoscopy in the last 12 months
- You have no history of colorectal cancer or certain inherited bowel conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This trial tests whether artificial intelligence can help doctors better detect and classify growths in the colon during a colonoscopy. You may benefit from potentially more accurate results.
This trial tests whether using artificial intelligence during a colonoscopy helps doctors find abnormal growths (polyps) in the colon more effectively than a standard colonoscopy alone. It may help detect problems early and prevent colon cancer.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This trial offers free screening for colorectal cancer using a stool test for people aged 45-74. It is for those who haven't had certain colorectal tests recently and are generally healthy.
This study uses artificial intelligence to help doctors predict if colon polyps are harmless during a colonoscopy. This could reduce the need for lab tests and save costs.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.